title: Phosphodiesterase activity in intrapulmonary arteries and veins of perinatal lambs.
abstract: The transition from fetal to newborn life is marked by a reduction in pulmonary vascular tone mediated by the intracellular second messengers, cGMP and cAMP. We have compared the rates of phosphodiesterase (PDE)-catalyzed hydrolysis of cGMP and cAMP in intrapulmonary vessels of fetal (146 +/- 2 days gestation) and newborn (3-7-day-old) lambs, each n = 6. Lung vessels of second to sixth generations were dissected and cytosol was prepared by differential centrifugation. PDE activity in cytosol was determined by radiometric assay of the hydrolysis of exogenous nucleotides at 30 degrees C for 10 min. Rates of hydrolysis (pmol/min/mg protein) of cGMP were 225 +/- 38 in fetal arteries and different from 151 +/- 7 in veins. In newborn vessels, the rates were 155 +/- 49 and 63 +/- 13 in arteries and veins, respectively. Rates of cAMP hydrolysis by the fetus were 80 +/- 11 in arteries and 45 +/- 16 veins. In newborn lambs the rates were 69 +/- 10 in arteries and different from 18 +/- 4 in veins. Inhibition of PDE activity by zaprinast, a cGMP-specific PDE inhibitor, and rolipram, a cAMP-specific PDE inhibitor, was more in veins of fetal and newborn lambs. Our data show that rates of hydrolysis of the cyclic nucleotides were faster in fetal vessels than in the newborn. We speculate that this would result in a greater accumulation of the cyclic nucleotides in newborn vessels, particularly the veins, and therefore endow the veins with less vascular tone.
authors.affiliation: UCLA School of Medicine, Harbor-UCLA Medical Center, Torrance, California, 90509, USA.
authors.forename: A C
authors.initials: AC
authors.lastname: Okogbule-Wonodi
authors.forename: B O
authors.initials: BO
authors.lastname: Ibe
authors.forename: B W
authors.initials: BW
authors.lastname: Yue
authors.forename: S
authors.initials: S
authors.lastname: Hsu
authors.forename: J U
authors.initials: JU
authors.lastname: Raj
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D000242:Cyclic AMP / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D003600:Cytosol / Q000201:enzymology; D005260:Female; D006868:Hydrolysis; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism*; D011247:Pregnancy; D011651:Pulmonary Artery / Q000196:embryology / Q000201:enzymology* / Q000254:growth & development*; D011667:Pulmonary Veins / Q000196:embryology* / Q000201:enzymology* / Q000254:growth & development; D011688:Purinones / Q000494:pharmacology; D011760:Pyrrolidinones / Q000494:pharmacology; D020889:Rolipram; D012756:Sheep
chemical_list: D010726:Phosphodiesterase Inhibitors; D011688:Purinones; D011760:Pyrrolidinones; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; C011145:zaprinast; D006152:Cyclic GMP; D020889:Rolipram